New data published in the Journal of Clinical Oncology show ELLENCE® (epirubicin hydrochloride injection) based chemotherapy regimen has survival benefits with low risk of adverse cardiac events
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
He who has never failed somewhere, that man can not be great.
~ Herman Melville